Analysis of FDA-approved drugs from 1985 to 2022 revealed a clear trend toward increasing molecular complexity, reflecting advances in both synthetic techniques and biological targets.
1
—
—
Analysis of FDA-approved drugs from 1985 to 2022 revealed a clear trend toward increasing molecular complexity, reflecting advances in both synthetic techniques and biological targets.